Bioventus (BVS) Insider Trading & Ownership $6.56 +0.03 (+0.46%) Closing price 05/29/2025 04:00 PM EasternExtended Trading$6.65 +0.09 (+1.37%) As of 05/29/2025 06:03 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Bioventus (NYSE:BVS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage32.90%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$902,025.00Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$858,393.53 Get BVS Insider Trade Alerts Want to know when executives and insiders are buying or selling Bioventus stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BVS Insider Buying and Selling by Quarter Bioventus Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/11/2025Anthony D'adamioSVPSell2,958$7.57$22,392.06 4/11/2025Mark Leonard SingletonCFOSell3,875$7.57$29,333.75 3/24/2025Mark Leonard SingletonCFOSell5,479$9.79$53,639.41 3/17/2025Katrina J ChurchSVPSell1,018$9.75$9,925.50 2/18/2025Anthony D'adamioSVPSell4,380$10.19$44,632.20 2/18/2025Mark Leonard SingletonCFOSell6,498$10.19$66,214.62 1/13/2025Robert E ClaypooleCEOSell28,786$9.10$261,952.60 12/23/2024Katrina J ChurchSVPSell2,535$10.53$26,693.55 12/23/2024Mark Leonard SingletonCFOSell10,733$10.53$113,018.49 8/19/2024John A BartholdsonDirectorBuy25,500$8.55$218,025.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 8/16/2024John A BartholdsonDirectorBuy80,000$8.55$684,000.00 6/21/2024Anthony D'adamioSVPSell5,904$5.57$32,885.28 6/21/2024Mark Leonard SingletonCFOSell9,219$5.57$51,349.83 6/17/2024Anthony D'adamioSVPSell11,308$5.84$66,038.72 6/17/2024Mark Leonard SingletonCFOSell13,753$5.84$80,317.52 (Data available from 1/1/2013 forward) BVS Insider Trading Activity - Frequently Asked Questions Who is on Bioventus's Insider Roster? The list of insiders at Bioventus includes Anthony D'adamio, Anthony P Bihl III, John A Bartholdson, John Nosenzo, Juniper Investment Company, Ll, Katrina J Church, Kenneth Michael Reali, Mark Leonard Singleton, Robert E Claypoole, and William A Hawkins. Learn more on insiders at BVS. What percentage of Bioventus stock is owned by insiders? 32.90% of Bioventus stock is owned by insiders. Learn more on BVS's insider holdings. Which Bioventus insiders have been buying company stock? The following insiders have purchased BVS shares in the last 24 months: Anthony P Bihl III ($55,020.60), John A Bartholdson ($3,146,061.52), and Juniper Investment Company, Ll ($299,946.87). How much insider buying is happening at Bioventus? Insiders have purchased a total of 873,007 BVS shares in the last 24 months for a total of $3,501,028.99 bought. Which Bioventus insiders have been selling company stock? The following insiders have sold BVS shares in the last 24 months: Anthony D'adamio ($197,517.26), Katrina J Church ($37,734.07), Mark Leonard Singleton ($442,739.61), and Robert E Claypoole ($261,952.60). How much insider selling is happening at Bioventus? Insiders have sold a total of 122,560 Bioventus shares in the last 24 months for a total of $939,943.54 sold. Bioventus Key ExecutivesMr. Mark L. Singleton (Age 54)Senior VP & CFO Compensation: $740.04kMr. Anthony D'Adamio (Age 63)Senior VP, General Counsel & Corporate Secretary Compensation: $705.38kMr. Robert E. Claypoole (Age 52)President, CEO & Director 1 recent tradesMr. Mike Crowe B.S.M.B.A., Senior Vice President of OperationsMr. David CrawfordVice President of Investor Relations & TreasurerMs. Katrina J. Church J.D. (Age 62)Senior VP & Chief Compliance Officer 2 recent tradesMs. Helen LeupoldSenior VP & Chief Human Resources OfficerMr. Larry ChenManaging Director of China & Asia Pacific More Insider Trading Tools from MarketBeat Related Companies Warby Parker Insider Trades NovoCure Insider Trades LeMaitre Vascular Insider Trades Enovis Insider Trades CONMED Insider Trades National Vision Insider Trades Tandem Diabetes Care Insider Trades Cadre Insider Trades Liquidia Insider Trades Artivion Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Dividend Investors Looking for an Edge? 3 Stocks Insiders BoughtMeta's Institutional & Insider Data Fuels Bulls Despite DisparityTurbulence for Joby Shares: What's Behind the Recent Dip?UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?Sprouts Stock: Insider Sales, But Strong Bullish Signals This page (NYSE:BVS) was last updated on 5/30/2025 by MarketBeat.com Staff From Our PartnersGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk’s Frightening Warning Forces Trump’s HandElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredUrgent: Make this trade before you hit your pillow tonight… Most people waste 8 hours every night… And 227,916 hours in their lifetime… Dreaming about the life they...Timothy Sykes | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bioventus Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bioventus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BVS Stock Free BVS Stock Alerts